Product Program year 2020 Source: CMS Open Payments

Viva

Device Implantable Cardioverter Defibrillators (ICDs)

Open in the dashboard

General payments

$50,338

449 payments

Research payments

$5,636,872

1,045 payments

Through program year 2020, $50,338 in general payments and $5,636,872 in research payments were reported against Viva (Implantable Cardioverter Defibrillators (ICDs)).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $11,442 110
2020 Research $2,010,590 484
2019 General $38,896 339
2019 Research $3,626,281 561

Breakdown

Who paid General payments · program years 2019–2020
  1. Medtronic Vascular, Inc. $50,338 449 payments
Top recipients General payments · program year 2020
  1. Michael Zile Advanced Heart Failure and Transplant Cardiology · Charleston, SC $4,896 43% · 2 payments
  2. Satish Tiyyagura Cardiovascular Disease · Fair Lawn, NJ $901 8% · 8 payments
  3. Rahul Kumar Clinical Cardiac Electrophysiology · Neptune, NJ $569 5% · 5 payments
  4. Michael Kasper Cardiovascular Disease · Saddle River, NJ $314 3% · 2 payments
  5. Felix Dailey-Sterling Cardiovascular Disease · Guttenberg, NJ $272 2% · 2 payments

The top 5 of 56 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Advanced Heart Failure and Transplant Cardiology Internal Medicine $4,901 43% · 2 practitioners
  2. Cardiovascular Disease Internal Medicine $3,122 28% · 16 practitioners
  3. Clinical Cardiac Electrophysiology Internal Medicine $1,935 17% · 20 practitioners
  4. Internal Medicine $654 6% · 6 practitioners
  5. Interventional Cardiology Internal Medicine $571 5% · 9 practitioners

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. South Carolina $4,896 43% · 1 recipient
  2. New Jersey $4,716 41% · 23 recipients
  3. Iowa $490 4% · 4 recipients
  4. New York $366 3% · 4 recipients
  5. Florida $290 3% · 4 recipients

The top 5 of 16 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

449 general · 1,045 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record